GLP-1 and dual GIP/GLP-1 agonists are a transformative advance in obesity medicine. But the evidence is unambiguous: substantial lean body mass loss accompanies the weight reduction these medications produce — and it frequently exceeds expected physiologic benchmarks. Just Right GLP-1™ extends your care — providing the personalized protein, supplement, and resistance-training support the guidelines call for, with a depth of follow-up that's hard to fit into a busy practice.
"Resistance training, adequate protein, and vitamin D supplementation are not extras. They are the standard of care for safe, sustainable weight loss on these medications."
A 2026 systematic review in Annals of Internal Medicine of 36 RCTs found the median share of weight loss attributable to muscle-based indices was 34.9%, with 68% of incretin interventions exceeding the ~25% lean-loss benchmark expected during weight reduction.1
Across the major trials, a striking share of what patients shed is lean tissue — including the skeletal muscle that underpins strength, metabolic rate, balance, and long-term independence. In the landmark STEP 1 trial of semaglutide, more than a third of the average weight reduction was lean body mass rather than fat.1 In SURMOUNT-1, tirzepatide reduced total lean mass by roughly eight and a half percentage points.2
And the pattern carries an uncomfortable irony: the agents that produce the most weight loss tend to be the least protective of muscle. The more effective the medication, the more deliberately lean mass has to be defended — yet that protection is almost never built into the prescription itself.3
Patients who regain weight after discontinuing a GLP-1 receptor agonist regain mostly fat, not muscle — potentially compounding the risk of sarcopenic obesity, the phenotype tied to the worst cardiometabolic outcomes.
Low muscle mass is an independent predictor of hard clinical outcomes — across community-dwelling adults, outpatients, inpatients, and nursing home residents.17
Every FDA-approved anti-obesity medication is approved as adjunctive therapy to a reduced-calorie diet and increased physical activity. This is not optional language — it is the labeled indication.1920
GLP-1s should be prescribed together with a structured exercise program, aiming for regular strength training at least 3× weekly plus at least 150 min of moderate-intensity aerobic exercise weekly to preserve muscle and bone mass.
The same advisory is explicit that increased protein intake alone is likely inadequate to preserve muscle mass in the absence of structured resistance training.7 The recommendation is echoed across the field — adjunctive lifestyle intervention is not a footnote, it is the consensus.21
The evidence is clear. The guidelines are explicit. But four realities of practice stand between the recommendation and the patient.
The average primary-care encounter does not allow for individualized protein calculations, resistance-training programming, supplement counseling, and ongoing body-composition monitoring.
Most prescribers are not exercise physiologists, dietitians, or sports nutritionists — and referral pathways to those specialists are often fragmented or unavailable.
Without a structured, accessible program, patients improvise protein targets, supplement choices, and exercise routines — often from conflicting, unvetted sources.
Even the right plan only helps if the patient can actually live it — getting the right supplements, fitting training into a real schedule, and keeping it going for months. Everyday friction at any step quietly stalls progress between visits.
The evidence is clear. The guidelines are explicit. The gap is delivery.
For patients on GLP-1s, achieving adequate protein is particularly challenging due to reduced appetite and taste aversions. Protein-rich foods should be consumed first in meals, and supplementation with high-protein shakes, bars, or fortified products may be necessary.7
In a randomized trial, one year of combined GLP-1 therapy with exercise training preserved bone mineral density, while GLP-1 therapy alone decreased it. The combination also produced larger reductions in abdominal fat and systemic inflammation.22
A meta-analysis confirmed creatine supplementation increases fat-free mass (WMD 0.82 kg; 95% CI 0.57–1.06) while reducing body-fat percentage, with effects most robust when combined with resistance training. Critically, under catabolic (energy-deficit) conditions, creatine inhibits the ubiquitin-proteasome pathway responsible for muscle protein breakdown and protects mitochondrial function.13
The ISSN position stand confirms HMB acts through a dual mechanism: enhancing muscle protein synthesis via mTORC1 activation and suppressing breakdown via the ubiquitin-proteasome pathway. An umbrella review of meta-analyses found HMB significantly increased fat-free mass and muscle-strength indices; in models of sustained energy deficit, it attenuated muscle loss and maintained grip strength.1415
Vitamin D plays a direct role in muscle protein synthesis, muscle-cell proliferation and differentiation, and mitochondrial function. Deficiency is highly prevalent among patients with obesity and those undergoing rapid weight loss, and is associated with impaired muscle function and increased fall risk.
Because the degree of deficiency varies widely among individuals, personalized dosing — rather than a one-size-fits-all approach — is essential. Just Right D™ uses evidence-based personalization to determine individual doses from 1,000 to 4,000 IU/day based on multiple patient-specific factors.
Personalized protein assessment — individualized daily targets from body composition, current intake, and GLP-1 status.
Daily HMB + creatine — evidence-based doses in a convenient daily format.
Personalized vitamin D (Just Right D™) — individualized 1,000–4,000 IU/day dosing with a six-month supply and reassessment.
Smartphone-delivered resistance training — short, practical, at-home exercises designed for adherence. No gym required.
Physician-created education — why muscle matters, how the program works, and when to consult their prescriber.
Six-month reassessment — because needs change as patients progress through weight loss.
Individualized protein planning, supplement dosing, resistance training programming, and ongoing reassessment require time and expertise that are hard to deliver in many practices at the frequency the evidence demands.
The program is designed to work alongside the prescriber's treatment plan. Patients are encouraged to share their program recommendations with their physician. No medications are prescribed. No medical advice is given that supersedes the prescriber's judgment.
The most effective program is the one patients actually follow. Supplements are delivered to the door. Exercises are delivered to the smartphone. Protein sources are chosen by the patient based on personal preference. The program is designed for real life.
Two simple ways to begin. Request a referral kit for your practice, or book a short call to see how Just Right GLP-1™ fits the patients you're already treating.
Prefer email? Reach us directly at [contact email].